Basal Cell Carcinoma — Trials

Basal Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

361 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 57
Recruiting: 32
Ph III recruiting: 3
Growth YoY: —
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 16.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (25)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06150144	The Efficacy and Safety of Using Intralesional 5-fluorouracil for Basal Cell Carcinoma	unknown	Phase 3	40	University of AleppoOTHER	1	Jan 2, 2024	clinicaltrials
NCT02242929	Surgery Versus Combined Treatment With Curettage and Imiquimod for Nodular Basal Cell Carcinoma(SCIN)	unknown	Phase 3	145	Maastricht University Medical CenterOTHER	1	Sep 24, 2021	clinicaltrials